The impact of n-3 fatty acids supplementation on the content of lipids in the pregnant women and the fetus

Not Applicable

Completed

• Conditions: Pregnancy; Pregnancy and Childbirth

• Registration Number: ISRCTN36705743
• Lead Sponsor: niversity of Mostar, School of Medicine

Brief Summary

2019 results in https://pubmed.ncbi.nlm.nih.gov/30315737/ (added 27/11/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-09
• Study Completion: 2017-11-30
• Last Update Posted: 7 December 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 87

Inclusion Criteria

1. Healthy pregnant women
2. Single pregnancy
2. BMI ( < 25kg/m2)
3. Provision of informed consent

Exclusion Criteria

1. Pregnancy terminated as preterm delivery
2. Pregnant women with chronic illness
3. Pregnant women with gestational diabetes mellitus or preeclampsia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Concentration of n-3 fatty acids in total serum lipids, measured using gas chromatography at the end of pregnancy/delivery<br> 2. Concentration of n-3 fatty acids in umbilical vein serum, measured using gas chromatography at time of birth<br> 3. Concentration of monounsaturated fatty acids in serum total lipids of umbilical vein serum, measured by gas chromatography at time of birth<br> 4. Concentration of monounsaturated fatty acids in serum total lipids of the mother's serum, measured by gas chromatography at the end of pregnancy<br>

Secondary Outcome Measures

Name	Time	Method
Weight of mother, measured by weighing scale at recruitment, 20th week of gestation, 30th week of gestation and before delivery